Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection ...Middle East

American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study results versus FIT at ACG High specificity for next-generation Cologuard test expected to minimize unnecessary follow-up colonoscopies,...

Hence then, the article about next generation cologuard test demonstrates high sensitivity and specificity in pivotal blue c study significantly outperforming fecal immunochemical testing fit for cancer and precancer detection was published today ( Sunday 22/10/2023 - 10:04 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection )

Also on site :

• Amazon’s ‘Powerful’ Electric Scrub Brush Helps Reach the Hard-to-Clean Spots — Tackle Grime Now for 40% Less
• Quote of the Day: Harper Lee on the Power of Empathy and Seeing the World Through Someone Else’s Eyes
• Land sold for Kushner-backed Albania resort suspected of forged deeds